Barry Vucsko
Senior Vice President, Strategic Development, EVERSANA INTOUCH
专长:
Barry Vucsko has more than 25 years of marketing, advertising, and consulting experience spanning more than 100 brands and several continents. His pharma advertising career has spanned creative, strategy and account leadership. Barry has extensive experience with HCP, Consumer and Managed Care targets, as well as Global and US launches for everything from oncology to ultra-rare and blockbuster treatments. He has a proven track record of developing integrated brand communications that achieve impact and drive business. Barry has an MBA from Indiana University’s Kelley School of Business and a BA from Columbia College Chicago.
Articles by Barry Vucsko
Making Cutting-Edge Cancer Treatments Accessible: Advancing CAR-T Therapy to the Community Practice
This article explores the significant advancements in CAR-T therapy and its transition from academic centers to community practices. CAR-T therapy, a revolutionary treatment for certain hematological malignancies, involves modifying a patient’s T-cells to target and destroy cancer cells. Historically limited to later lines of treatment due to potential side effects and the need for individualized […]
Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024
Every year, the European Society for Medical Oncology (ESMO) brings together experts from pharma, research and advocacy organizations, and healthcare providers (HCPs) to hear about the year’s biggest oncology breakthroughs. With the theme “Shaping the Future of Anticancer Therapies,” ESMO 2024 saw record crowds and focused on advancements across immuno-oncology, antibody drug conjugates (ADCs) and […]
The Necessity of Mapping the Tumor Journey for Oncology Marketers
EVERSANA INTOUCH has been pioneering a Tumor Journey that considers the complex, multi-factorial decision making that permeates every stage of oncologic patient care. Oncology Marketing has been slow in evolving to consider the complexities of diagnosis, treatment, and overall patient care decisions made by multiple stakeholders. We continue to rely on traditional patient journeys and […]